Correlation Between Oncology Pharma and Regen BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncology Pharma and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncology Pharma and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncology Pharma and Regen BioPharma, you can compare the effects of market volatilities on Oncology Pharma and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncology Pharma with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncology Pharma and Regen BioPharma.

Diversification Opportunities for Oncology Pharma and Regen BioPharma

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Oncology and Regen is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Oncology Pharma and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Oncology Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncology Pharma are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Oncology Pharma i.e., Oncology Pharma and Regen BioPharma go up and down completely randomly.

Pair Corralation between Oncology Pharma and Regen BioPharma

Given the investment horizon of 90 days Oncology Pharma is expected to generate 19.08 times more return on investment than Regen BioPharma. However, Oncology Pharma is 19.08 times more volatile than Regen BioPharma. It trades about 0.28 of its potential returns per unit of risk. Regen BioPharma is currently generating about -0.28 per unit of risk. If you would invest  0.01  in Oncology Pharma on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Oncology Pharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Oncology Pharma  vs.  Regen BioPharma

 Performance 
       Timeline  
Oncology Pharma 

Risk-Adjusted Performance

29 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Oncology Pharma are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Oncology Pharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Regen BioPharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Oncology Pharma and Regen BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncology Pharma and Regen BioPharma

The main advantage of trading using opposite Oncology Pharma and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncology Pharma position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.
The idea behind Oncology Pharma and Regen BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments